Viewing Study NCT05422066


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-04-16 @ 5:07 PM
Study NCT ID: NCT05422066
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2022-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
Sponsor: Li Zhiming
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module